Meeting
2018 Gastrointestinal Cancers Symposium
Prescribing patterns for FOLFIRINOX in the real world.
Authors
Chad Michael Guenther
University of Texas Southwestern Medical Center, Dallas, TX
Chad Michael Guenther , Nizar Bhulani , Adam Korenke , Jenny Jing Li , Leticia Khosama , Samira K. Syed , Syed Mohammad Ali Kazmi , Naga Koteswari Cheedella , Sirisha Karri , Jay Lohrey , Aravind Sanjeevaiah , Udit N. Verma , John Vernon Cox , Yull Edwin Arriaga , Muhammad Shaalan Beg
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 463)
DOI
10.1200/JCO.2018.36.4_suppl.463
Abstract #
463
Poster Bd #
M10
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Low skeletal muscle area and association with toxicity and hospitalization with chemotherapy in advanced non–small cell lung cancer.
First Author: Anurag Saraf
First Author: Juliana Souza
Poster
2018 Gastrointestinal Cancers Symposium
Clinical outcomes of FOLFIRINOX and gemcitabine/nab-paclitaxel in the real world setting.
First Author: Fernando Franco Franco
Poster
2018 Gastrointestinal Cancers Symposium
The relationship between dose to skeletal muscle area ratio and gemcitabine nab-paclitaxel toxicity in pancreatic ductal adenocarcinoma.
First Author: Rachel Wong